Dysregulation of JAK/STAT signaling can lead to malignant transformation, including the development of myeloproliferative neoplasms, acute myeloid leukemia (54–57), and T cell acute lymphoblastic leukemia (58). This evidence concerns the gene SOAT1 and T-cell acute lymphoblastic leukemia.